• Nut consumption has been associated with improved nutrient intake and diet quality and improved health outcomes, including those related to cardiovascular disease. (cdc.gov)
  • For each patient with a qualifying index hospitalization, data were collected over the next 12 months to identify outcomes of interest. (medpagetoday.com)
  • Primary outcomes included the CKD-specific ACSCs of hyperkalemia, malignant hypertension, volume overload, and heart failure, and patients with CKD were classified as having at least 1 ACSC-related hospitalization or no ACSC-related hospitalization during the follow-up period. (medpagetoday.com)
  • Although several mechanisms exist by which marijuana use might contribute to the development of chronic cardiovascular conditions or acutely trigger cardiovascular events, there are few data regarding marijuana/THC use and cardiovascular disease outcomes. (erowid.org)
  • Research directions might include more studies of cardiovascular disease outcomes and relationships of marijuana with cardiovascular risk factors, studies of metabolic and physiologic effects of chronic marijuana use that may affect cardiovascular disease risk, increased understanding of the role of the cannabinoid receptor system in cardiovascular regulation, and studies to determine if there is a therapeutic role for cannabinoids in blood pressure control or for neuroprotection after stroke. (erowid.org)
  • It is important to note that higher intradialytic symptoms result in poor outcomes, including decreased quality of life, decreased dialysis dose, depression, and mortality [ 3 , 4 ]. (hindawi.com)
  • No large studies have specifically compared long-acting insulin alone with long-acting plus short-acting insulin with regard to cardiovascular outcomes. (healthpartners.com)
  • Research shows that being breastfed leads to better outcomes with respect to cardiovascular disease in later life ( UNICEF ). (breastfeedingnetwork.org.uk)
  • Not knowing the answer, I dug deeper into the published literature about cardiovascular outcomes after KD and found that a significant knowledge gap existed, particularly in children who did not develop coronary artery aneurysms during their acute illness. (newswise.com)
  • The SGLT2 inhibitor empagliflozin was the first glucose-lowering drug to show an improvement in cardiovascular outcomes in a large randomized controlled clinical trial. (ccs.ca)
  • The primary efficacy outcomes were MACE and a composite of cardiovascular death or HHF. (ccs.ca)
  • The outcomes analyzed included mortality combined with the necessity of new renal replacement therapy, severe cardiovascular events, and hospitalization. (biomedcentral.com)
  • The primary composite outcome was death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, as analyzed in the pooled empagliflozin group versus the placebo group. (nih.gov)
  • CONCLUSIONS AND RELEVANCE: Findings of this retrospective cohort study suggested an increased risk of all-cause mortality and a decreased risk of acute myocardial infarction for the LA plus SA group compared with the LA group. (healthpartners.com)
  • The primary safety outcome was a composite of major adverse cardiovascular events (MACE), defined as cardiovascular death, myocardial infarction, or ischemic stroke. (ccs.ca)
  • Aetna considers the use of chelation therapy experimental and investigational in the prevention and treatment of cancer, cardiovascular disease (e.g., atherosclerotic cardiovascular disease , coronary artery disease, individuals who had a myocardial infarction), neurodegenerative diseases (e.g. (aetna.com)
  • The primary endpoints were nonfatal stroke, nonfatal myocardial infarction (MI), and cardiovascular death. (medscape.com)
  • We aim to investigate the temporal variations in the association between ambient temperature and hospitalizations for cardiovascular diseases. (earth.com)
  • This suggests that KD survivors should be screened at regular intervals for cardiovascular diseases and associated risk factors," says Dr. Robinson. (newswise.com)
  • The number of cases of mortality due to male diseases is higher in men, considering the period from 2008 to 2017. (bvsalud.org)
  • There is a tendency towards stability in cases of mortality and hospitalization due to liver diseases in the Western Amazonia. (bvsalud.org)
  • This study was carried out to identify the mortality and hospitalization due to liver diseases, discover its possible causes, and identify health actions that influence the conditions and the improvement of quality of life of individuals in the region studied. (bvsalud.org)
  • Creating means and strategies aimed at health promotion and prevention can contribute to the awareness of professionals and the population and guarantee better results in the conditions of prognosis and treatment of patients affected by liver diseases, ensuring the quality of life and lower rates of morbidity and mortality. (bvsalud.org)
  • Note: Noncommunicable diseases (NCDs) considered in this Strategy refer to four main noncommunicable diseases (cardiovascular disease, cancer, diabetes and obstructive pulmonary disease), which account for more than 65% of all deaths in Seychelles, and to four main underlying risk behaviours (tobacco use, unhealthy nutrition, physical inactivity and harmful use of alcohol). (who.int)
  • We know, from our own studies and experience, that four main noncommunicable diseases (cardiovascular disease, cancer, diabetes and obstructive pulmonary disease) account for more than 65% of all deaths in Seychelles. (who.int)
  • VYNDAQEL and VYNDAMAX are transthyretin stabilizers indicated for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis in adults to reduce cardiovascular mortality and cardiovascular-related hospitalization. (nih.gov)
  • The program's goal is to reduce cardiovascular mortality andcardiovascular re-hospitalization in the post-acute period among patientssuffering from acute decompensated heart failure. (drugdiscoverynews.com)
  • The high incidence of cardiovascular morbidity and mortality in the setting of CKD along with the low utilization of coronary revascularization and standard medical therapies has generated interest in extending this concept to those with CKD and the idea that increased screening for and identification of coronary disease could reduce cardiovascular mortality in CKD. (lww.com)
  • These events should include cardiovascular mortality, MI, and stroke and can include hospitalization for acute coronary syndrome , urgent revascularization procedures, and possibly other end points. (medscape.com)
  • A short-term infusionof cenderitide has demonstrated positive effects on patients' cardiovascularand renal parameters, and Nile feels that continuous and extended infusionsthrough a subcutaneous pump could provide sustained symptomatic relief,contributing to fewer post-acute hospitalizations and continued improvement incardio-renal functions. (drugdiscoverynews.com)
  • Hospitalization during the post-acute period, 90 days afteradmission for ADHF, is a substantial issue, as the American Heart Association notes that there are more than 1.2 million ADHF admissions per year in theUnited States and 40 percent of those patients return to the hospital. (drugdiscoverynews.com)
  • The only independent procedure-related predictor for all-cause mortality was acute kidney injury. (unipi.it)
  • Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. (cdc.gov)
  • Previous results were based on mortality data from China ( 1 ), and underlying conditions include cardiovascular disease, diabetes, chronic obstructive pulmonary disease, asthma, hypertension, or cancer other than skin. (cdc.gov)
  • Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019-COVID-NET, 14 States, March 1-30, 2020. (cdc.gov)
  • Disorders of mineral metabolism are independently associated with mortality and morbidity associated with cardiovascular disease and fracture in hemodialysis patients. (nih.gov)
  • IDH increases risks of cardiovascular disease and ultimately hospitalizations and mortality. (umich.edu)
  • Investigators at the University of Hawaii recently reported that, among patients hospitalized with chronic kidney disease, 1.7% experienced a preventable hospitalization and 12.3% were super-utilizers of inpatient services over a 12-month follow-up period. (medpagetoday.com)
  • Approximately 2% of patients with chronic kidney disease (CKD) may have been able to avoid 1 or more hospitalizations, and 12.3% of those with CKD are "super-utilizers" of inpatient services, according to a new study from Hawaii. (medpagetoday.com)
  • 2 It's associated with complications of end-stage kidney disease, dialysis dependence, cardiovascular events, and increased mortality. (medpagetoday.com)
  • That report presents information on the prevalence and incidence of diabetes, diabetes mortality, hospitalizations, and several diabetes complications, including cardiovascular disease, lower extremity amputations, ketoacidosis, and end-stage renal disease. (cdc.gov)
  • At present, state-specific data can be obtained only for mortality and end-stage renal disease. (cdc.gov)
  • For statistics on mortality and end-stage renal disease, we used actual counts from vital statistics records and Medicare data, respectively. (cdc.gov)
  • A large cohort study showed no association of marijuana use with cardiovascular disease hospitalization or mortality. (erowid.org)
  • Results: S-Alb was independent protective factor for mortality, all-cause hospitalization, hospitalization for cardiovascular or cerebrovascular disease and hospitalization for infection. (researchsquare.com)
  • 18 years and underwent MHD for at least 3 months, exclusion criteria were hospitalization within 3 months before the study, combined with uncured malignant tumor or active liver disease. (researchsquare.com)
  • For inclusion in this review, the papers had to present results specifically for women, use the end point of all cause mortality (rather than cause specific mortality, such as cardiovascular disease mortality), and examine the association of physical activity or fitness with all cause mortality. (bmj.com)
  • Hypertension is a risk factor for cardiovascular disease like heart attacks and stroke. (salon.com)
  • To obtain sufficient end points to allow a meaningful estimate of risk, the phase 2 and phase 3 programs should include patients at higher risk of cardiovascular events, such as patients with relatively advanced disease, elderly patients, and patients with some degree of renal impairment," the FDA states in the guidance document. (medscape.com)
  • Breastfeeding has many factors to protect the mother and baby from future cardiovascular disease. (breastfeedingnetwork.org.uk)
  • Schwartz (2009) studied 139,681 women who had breastfed for more than 12 months across their lactations and showed a 10-15% reduction in hypertension, diabetes, hyperlipidaemia, and cardiovascular disease than those who had never breastfed. (breastfeedingnetwork.org.uk)
  • Newswise - ATLANTA - New research shows that children with Kawasaki Disease remain at an increased risk for cardiovascular events more than 10 years after hospitalization for their condition, highlighting the need for long-term heart disease surveillance and risk reduction strategies for these young patients. (newswise.com)
  • They determined the rates of cardiovascular events, major adverse cardiac events (such as heart attack or stroke) and death, comparing children who had KD with those who were not exposed to the disease. (newswise.com)
  • They found that, among 4,597 KD survivors, 746 or 16.2% experienced cardiovascular events compared with 5.2% of children without the disease. (newswise.com)
  • The most frequent cardiovascular events experienced by KD survivors were ischemic heart disease, arrhythmias, high blood pressure and peripheral vascular disease. (newswise.com)
  • KD survivors were at higher risk of heart problems compared to patients who did not have the disease and they experienced cardiovascular events sooner. (newswise.com)
  • As cited in a clinical bulletin from the American College of Cardiology (ACC), in case reports of novel coronavirus (COVID-19) infection in China the mortality rate was approximately _____ in patients with comorbid cardiovascular disease (CVD). (the-hospitalist.org)
  • For patients with type 2 diabetes and without established cardiovascular disease, CDEC recommends that a sulfonylurea be added to metformin for adults inadequately controlled on metformin alone. (cadth.ca)
  • [41] In 2017, the CCS HF guidelines [15] recommended the use of SGLT2 inhibitors for prevention of HF events in patients with type 2 diabetes and known history of cardiovascular disease. (ccs.ca)
  • [42] The EMPA-REG OUTCOME trial randomized 7020 patients with type 2 diabetes and established cardiovascular disease (with estimated glomerular filtration rate [eGFR] 30 mL/min/1.73 m2) to receive either empagliflozin 10 mg or 25 mg or placebo. (ccs.ca)
  • 50 years with 2 risk factors for cardiovascular disease were randomized to receive canagliflozin (either 100 or 300 mg/d), or placebo. (ccs.ca)
  • A subsequent analysis [45] showed that this benefit occurred in patients with and without a preexisting atherosclerotic cardiovascular disease. (ccs.ca)
  • In the D apagliflozin E ffect on C ardiovascu lar E vents (DECLARE)- T hrombolysis i n M yocardial I nfarction (TIMI) 58 study, [46] dapagliflozin vs placebo was evaluated in 17,160 patients, 10,186 of whom did not have documented existing atherosclerotic cardiovascular disease. (ccs.ca)
  • 95% CI, 0.61-0.88) and similar relative benefits were observed in patients with or without preexisting atherosclerotic cardiovascular disease or HF. (ccs.ca)
  • Data from the Massachusetts Department of Public Health and the Massachusetts Children's Health Insurance Program indicated striking disparities in mortality and hospitalization related to cardiovascular disease (CVD), heart attack, and stroke among certain residents of the state, particularly those in western Massachusetts. (nih.gov)
  • In 1986, it emphasized the need for further examination of the relationship between "involuntary smoking" and cardiovascular disease in The Health Consequences of Involuntary Smoking (HHS, 1986). (nationalacademies.org)
  • Most recently, in The Health Consequences of Involuntary Exposure to Tobacco Smoke (HHS, 2006), it concluded that exposure to secondhand smoke could have immediate adverse effects on the cardiovascular system in adults and that it causes coronary heart disease. (nationalacademies.org)
  • 1974). In addition, the 1990 report The Health Benefits of Smoking Cessation: A Report of the Surgeon General (HHS, 1990) and the National Cancer Institute's Monograph 8: Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control (NCI, 1997) discussed the cardiovascular benefits of smoking cessation. (nationalacademies.org)
  • On the basis of a systematic review of 20 cohort studies, Critchley and Capewell (2003) estimated that there was a 36% reduction in mortality in patients with coronary heart disease who quit smoking compared with those who continued smoking. (nationalacademies.org)
  • Their data provide evidence that limitation of secondhand-smoke exposure should reduce risk of mortality from coronary heart disease substantially. (nationalacademies.org)
  • Coronary artery disease (CAD) is a leading cause of mortality in patients with CKD, with the prevalence of CAD increasing dramatically as GFR decreases below 60-75 ml/min per 1.73 m 2 . (lww.com)
  • In the general population, screening for cardiovascular disease (CVD) in asymptomatic patients requires testing for risk factors and risk assessment. (lww.com)
  • In addition to traditional risk factors such as hypertension and diabetes mellitus, individuals with CKD are exposed to nontraditional risk factors such as anemia, inflammation, and oxidative stress, change in mineral and bone disease homeostasis, and other factors that have been implicated in the pathogenesis of atherosclerosis and may increase the incidence of cardiovascular events ( 1 ). (lww.com)
  • There was a 20% reduction in the primary endpoint of cardiovascular mortality, stroke, MI, coronary revascularization, unstable angina, and resuscitation from death in the amlodipine/benazepril arm (9.6%) compared with the HCTZ/benazepril arm (11.8%) (p (acc.org)
  • Cardiovascular death, stroke, and MI were also reduced by 21% (p = 0.002). (acc.org)
  • Other endpoints, including cardiovascular mortality, stroke, and resuscitated sudden death were similar between the two groups. (acc.org)
  • Treatment with long-acting plus short-acting insulin was not associated with increased risks of congestive heart failure, stroke, or cardiovascular mortality. (healthpartners.com)
  • There was no difference for the endpoints of nonfatal MI and nonfatal stroke, but cardiovascular deaths happened in 3.7% in the active treatment group as compared with 5.9% in the placebo group. (medscape.com)
  • However, respiratory dysfunction remains responsible for much of the morbidity and mortality associated with the disorder. (wikipedia.org)
  • The declines in HIV-related deaths due to treatment are being challenged by increasing morbidity and mortality associated with co- infections, such as tuberculosis and viral hepatitis. (who.int)
  • Internationally, the prevalence of asthma (and related hospitalizations and mortality) continues to rise in adults and children. (cdc.gov)
  • Given the established association between CKD and super-utilization, Prabhudesai and colleagues sought to "determine the prevalence of potentially preventable hospitalizations and identify super-utilization among CKD patients. (medpagetoday.com)
  • 1 For the present study, they examined the prevalence of hospitalizations for CKD-specific ACSCs and super-utilization of care in Hawaii. (medpagetoday.com)
  • PHOENIX -- Global experience with the novel Intrepid transapical transcatheter mitral valve replacement (TMVR) device through 2 years showed high risks of mortality and complications, raising concerns that might not be alleviated by the planned shift to a transfemoral approach. (medpagetoday.com)
  • The effects of empagliflozin, an inhibitor of sodium-glucose cotransporter 2, in addition to standard care, on cardiovascular morbidity and mortality in patients with type 2 diabetes at high cardiovascular risk are not known. (nih.gov)
  • Patients with type 2 diabetes at high risk for cardiovascular events who received empagliflozin, as compared with placebo, had a lower rate of the primary composite cardiovascular outcome and of death from any cause when the study drug was added to standard care. (nih.gov)
  • IMPORTANCE: Cardiovascular events and mortality are the principal causes of excess mortality and health care costs for people with type 2 diabetes. (healthpartners.com)
  • OBJECTIVE: To compare cardiovascular events and mortality in adults with type 2 diabetes receiving long-acting insulin who do or do not add short-acting insulin. (healthpartners.com)
  • December 18, 2008 (Silver Spring, Maryland) - The Food and Drug Administration is now recommending that all new drugs developed for the treatment of type 2 diabetes show that they do not increase the risk of cardiovascular events. (medscape.com)
  • FDA announces new recommendations on evaluating cardiovascular risk in drugs intended to treat type 2 diabetes. (medscape.com)
  • All of these effects represent potentially favourable changes that might lead to a reduction in incident HF in patients with type 2 diabetes, as initially shown in the landmark Empa gliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients - R emoving E xcess G lucose (EMPA-REG OUTCOME) trial. (ccs.ca)
  • [41] The Can agliflozin Cardio v ascular A ssessment S tudy- R enal (CANVAS-R) Program was the second major study of an SGLT2 inhibitor to show cardiovascular benefit in patients with type 2 diabetes. (ccs.ca)
  • The goal of this trial was to evaluate the safety and efficacy of the combination of amlodipine/benazepril, compared with hydrochlorothiazide (HCTZ)/benazepril in reducing cardiovascular morbidity and mortality in high-risk patients with systolic hypertension. (acc.org)
  • The fixed dose combination of amlodipine/benazepril would be superior to HCTZ/benazepril in reducing cardiovascular mortality and morbidity in high-risk patients with hypertension. (acc.org)
  • The results of this large, randomized trial indicate that a single combination therapy of amlodipine/benazepril is superior to HCTZ/benazepril in the reduction in blood pressure as well as cardiovascular endpoints in patients with high-risk hypertension. (acc.org)
  • In the setting of CKD, hyperkalemia, malignant hypertension, volume overload, and heart failure are important ambulatory care-sensitive conditions (ACSCs), which refer to those health conditions that can be managed successfully with good outpatient care to potentially prevent hospitalizations. (medpagetoday.com)
  • Elderly patients with asthma face disproportionate morbidity, mortality, and cost when compared with younger patient groups. (medscape.com)
  • During a follow-up of nearly 5 years, iPOST reduced long-term occurrence of cardiovascular mortality and hospitalization for heart failure in patients with STEMI treated with PCI but without thrombectomy. (lu.se)
  • For determining associations among disorders of mineral metabolism, mortality, and morbidity in hemodialysis patients, data on 40,538 hemodialysis patients with at least one determination of serum phosphorus and calcium during the last 3 mo of 1997 were analyzed. (nih.gov)
  • Identifying the causes of ambulatory care-sensitive condition hospitalizations will help [in] formulating policies for effective and focused outpatient management for patients with CKD and in turn reduce the risk of heart failure and hyperkalemia and ultimately reduce the cost associated with preventable hospitalizations. (medpagetoday.com)
  • Adult patients with CKD and a first hospitalization between January 2015 and August 2016 were included in the study. (medpagetoday.com)
  • Patients who died during their index hospitalization or during the 12-month follow-up period were excluded from the study. (medpagetoday.com)
  • In total, 12,679 patients had a first CKD-related hospitalization during the study period. (medpagetoday.com)
  • The relative risk of cardiovascular hospitalization associated with high temperatures was found to increase over time, regardless of the patients' age, sex, or climate zone. (earth.com)
  • In these patients VASOTEC improves symptoms, increases survival, and decreases the frequency of hospitalization (see CLINICAL PHARMACOLOGY , Heart Failure , Mortality Trials for details and limitations of survival trials ). (rxlist.com)
  • In maintenance hemodialysis patients, there were "U-shaped" relationships between serum albumin level and mortality or hospitalization, negative linear relationship between serum albumin level and hospitalization for infection. (researchsquare.com)
  • Based on that two-day meeting, the FDA is now asking sponsors for more stringent clinical trials that collect data on cardiovascular end points, as well as studies that include real-world patients likely to be seen in clinical practice. (medscape.com)
  • Upon discharge, patients were randomized 2 to 1 to either receive the WCD plus guideline-directed medical therapy or guideline-directed medical therapy alone for 90 days to determine the potential mortality benefit of the WCD. (acc.org)
  • The trial showed that in patients with ATTR-CM, acoramidis was consistently associated with clinical benefits as reflected in the primary hierarchical analysis, with 58% of the win ratio ties broken by all-cause mortality and cardiovascular-related hospitalizations, and an overall win ratio of 1.8 that was highly statistically significant. (news-medical.net)
  • The high mortality risk in these patients was notable, said session panelist Gorav Ailawadi, MD, of the University of Michigan in Ann Arbor. (medpagetoday.com)
  • patients over the age of 50 also represent the largest hospitalization cases. (bvsalud.org)
  • We need to know what the best treatments are for our patients if we want to prevent cardiovascular deaths. (medscape.com)
  • The key secondary composite outcome was the primary outcome plus hospitalization for unstable angina. (nih.gov)
  • however, failure to meet these secondary prevention goals-and resultant hospitalization-are common. (medpagetoday.com)
  • A search was performed on secondary databases, referring to the number of deaths and hospitalizations. (bvsalud.org)
  • Currently, public health programs at the local, state, and federal levels are directed toward reducing the morbidity and mortality from diabetes. (cdc.gov)
  • Diabetes Drugs Must Now Clear Cardiovascular Hurdle, Says FDA - Medscape - Dec 18, 2008. (medscape.com)
  • Given the lack of an increase in major cardiovascular events or cardiovascular mortality, the increased all-cause mortality with long-acting plus short-acting insulin may be explained by noncardiovascular events or unmeasured confounding. (healthpartners.com)
  • The report, from the Center for Drug Evaluation and Research (CDER), recommends that sponsors establish an independent cardiovascular end points committee to prospectively assess cardiovascular events during all phase 2 and phase 3 trials. (medscape.com)
  • The treatment of Familial Hypercholesteraemia is recommended to reduce the risk of future cardiovascular events. (breastfeedingnetwork.org.uk)
  • However, the risk of long-term cardiovascular events after childhood KD diagnosis remains unknown. (newswise.com)
  • They launched this study to determine the risk and timing of long-term cardiovascular events and death among KD survivors. (newswise.com)
  • A lower estimated glomerular filtration rate did not predict a higher probability of severe cardiovascular events, except when using the CKD-EPIcyst equation. (biomedcentral.com)
  • By calculating the net reclassification improvement, CKD-EPIcyst and CKD-EPIcreatcyst were shown to predict mortality (+25% and +18%) and severe cardiovascular events (+7% and +9%) with the highest accuracy. (biomedcentral.com)
  • The new CKD-EPIcreatcyst and CKD-EPIcyst equations appear to be better predictors of mortality and severe cardiovascular events. (biomedcentral.com)
  • In this study, we used the data from the BELFRAIL study to analyze the ability of GFR, estimated by older equations like the MDRD and CKD-EPI creatinine equations and the three new GFR equations, to predict mortality, necessity of renal replacement therapy (RRT), hospitalization, and severe cardiovascular events. (biomedcentral.com)
  • Among late adverse events including bioprosthetic valve failure, COPD exacerbation/respiratory failure requiring hospitalization was the only independent predictor of mortality. (unipi.it)
  • Freedom from re-hospitalization for cardiovascular events was 80%, 57% and 40% at 1-, 5- and 8-years. (unipi.it)
  • In the analysis pooling data from a pilot study and the APOLLO trial, the high-risk patient population studied with at least moderate-severe symptomatic mitral regurgitation (MR) not considered candidates for surgical treatment had "reduced but continued primary endpoint events after 30 days, largely due to underlying myocardial dysfunction," reported Martin B. Leon, MD, of Columbia University/NewYork-Presbyterian Hospital and the Cardiovascular Research Foundation in New York City. (medpagetoday.com)
  • 10% at 10 years) of cardiovascular events with electrocardiography-based screening, given the uncertain harms and low likelihood that screening will result in a change in risk management. (lww.com)
  • However, even in the absence of symptoms, individuals with CKD are likely to have moderate or high risks of cardiovascular events. (lww.com)
  • Mortality associated with cardiovascular events. (who.int)
  • The primary endpoint, analyzed at 30 months, was a hierarchical analysis by the Finklestein-Schoenfeld method of all-cause mortality, cardiovascular-related hospitalization, NT-proBNP, and 6MWD. (news-medical.net)
  • Cardiovascular risk reduction strategies should be implemented for all KD survivors, including healthy active lifestyle counselling and early intervention when cardiovascular risk factors are identified. (newswise.com)
  • Previously, the ATTR-ACT trial of tafamidis in ATTR-CM demonstrated a reduction in all-cause mortality, cardiovascular-related hospitalization and declines in functional capacity by 6 minute walk distance (6MWD) and quality of life assessed by the Kansas City Cardiomyopathy Questionnaire overall summary score (KCCQ-OS), as compared with placebo. (news-medical.net)
  • Kaplan-Meier estimates of survival and the Cox proportional hazards model were used to identify independent predictors of all-cause-mortality. (unipi.it)
  • Age-adjusted baseline predictors of mortality included impaired kidney function and severe COPD. (unipi.it)
  • The primary end point was a combination of cardiovascular mortality and hospitalization for heart failure. (lu.se)
  • Potentially preventable hospitalizations were most commonly due to heart failure or hyperkalemia, Prabhudesai and colleagues reported in BMC Nephrology . (medpagetoday.com)
  • The Framingham Heart Study , a seminal trial following a cohort of Americans from Framingham, Massachusetts, since 1948, has yielded many landmark insights into cardiovascular risk, morbidity, and mortality. (salon.com)
  • It's also the first therapy associated with a mortality benefit above and beyond standard medical therapy immediately after heart attack. (acc.org)
  • Generally, the three-month mortality rate for people recovering from a heart attack who also have reduced heart function is around 5 percent, Olgin said, and that is with optimal medical management. (acc.org)
  • The combined rate of all-cause mortality and heart failure hospitalization rose from 41.3% at 1 year to 52.8% at 2 years, he noted at the annual TVT conference hosted by the Cardiovascular Research Foundation. (medpagetoday.com)
  • To help clinicians determine the potential need for cardiovascular interventions, The American Heart Association recommends performing a 10-year risk assessment such as the Framingham risk score (which includes age, sex, and blood pressure) to assess 10-year risk of CVD beginning at age 40 and repeating every 5 years. (lww.com)
  • Cardiovascular Dysautonomia in older adults. (lu.se)
  • The study was focused on data involving 1,855,717 cardiovascular hospitalizations in Queensland between 1995 and 2016. (earth.com)
  • analizar la tendencia temporal de cobertura de Estrategia de Salud de la Familia (ESF) en Brasil, las unidades de la federación (UFs) y regiones, entre 2006-2016. (scielo.br)
  • ABSTRACT In Libya, little is known about HIV-related hospitalizations and in-hospital mortality. (who.int)
  • Fueled by the ubiquity of data, an explosion of medical journals, and the unchecked incentive to publish, cardiovascular observational research has descended more deeply into a credibility crisis. (medscape.com)
  • Updated results are based on US hospitalization data ( 2 ), and obesity is substituted for cancer as an underlying condition. (cdc.gov)
  • The conclusive data-or any data-that definitively shows that cutting back on dietary sodium reduces mortality or significantly reduces cardiovascular morbidity. (salon.com)
  • Studies, however, will likely be longer and more expensive, in order to provide sufficient data on cardiovascular risk for these new therapies. (medscape.com)
  • In addition to showing cardiovascular safety, the agency is asking companies to provide comprehensive data collection that will allow for appropriate meta-analyses to be performed at the time of their completion. (medscape.com)
  • Nguyen (2019) reported that ever breastfeeding was associated with lower risk of CVD hospitalisation and mortality compared with never breastfeeding, and breastfeeding ≤12 months/child was significantly associated with lower risk of CVD hospitalisation. (breastfeedingnetwork.org.uk)
  • Also determined was whether disorders of mineral metabolism were associated with all-cause, cardiovascular, infection-related, fracture-related, and vascular access-related hospitalization. (nih.gov)
  • Hyperphosphatemia and hyperparathyroidism were significantly associated with all-cause, cardiovascular, and fracture-related hospitalization. (nih.gov)
  • Last July, the Endocrinologic and Metabolic Drugs Advisory Committee voted overwhelmingly in favor of requiring sponsors to conduct long-term clinical trials or provide equivalent evidence ruling out an unacceptable cardiovascular safety risk. (medscape.com)
  • AIDS-related hospitalizations and mor- examine the clinical and laboratory laboratory results at the time of hospi- tality, and improved the overall survival factors associated with in-hospital mor- tal admission and before rehydration, among affected individuals ( 2 - 5 ). (who.int)
  • Objectives To assess the feasibility of extracting radiomics signal intensity based features from the myocardium using cardiovascular magnetic resonance (CMR) imaging stress perfusion sequences. (researchgate.net)
  • Mortality rates in ESRD are unacceptably high. (nih.gov)
  • To create these estimates, we have applied national rates for a particular condition of interest (e.g., hospitalizations for lower extremity amputations) to the population within a state to estimate the number of persons with the condition. (cdc.gov)
  • they are also charged with mortality rates and hospitalizations. (bvsalud.org)
  • besides, the hospitalization and mortality rates showed stability among the years studied. (bvsalud.org)
  • Elder abuse is independently associated with increased mortality risk, especially for cardiovascular related mortality. (spokanejournal.com)
  • Current HAART use was independently associated with low risk of in-hospital mortality (OR 0.33), while central nervous system symptoms (OR 4.12), sepsis (OR 6.98) and low total lymphocyte counts (OR 3.60) were associated with increased risk. (who.int)
  • During the follow-up period, which was an average of 2.9 years, 124 participants died, 7 required renal replacement therapy, 271 were hospitalized, and 73 had a severe cardiovascular event. (biomedcentral.com)
  • In this study, late presentation with severe immunosuppression was common, and was associated with significant in-hospital mortality. (who.int)
  • 2012]. Noncancer health effects also are associated with diesel exhaust exposure, including immunologic, respiratory, and cardiovascular effects. (cdc.gov)
  • However, we are not aware of any population-based study that has examined the prospective association between elder abuse and the rate of hospitalization in a community-dwelling population. (spokanejournal.com)
  • The study results indicate an unadjusted mean annual rate of hospitalization for those who had experienced elder abuse was 1.97 hospital admissions per year, compared with 0.62 for those who hadn't suffered such abuse. (spokanejournal.com)
  • The rate of all-cause mortality increased from 13.1% in the first 30 days to 16.3% in year 1 to 12.4% in year 2. (medpagetoday.com)
  • A new study led by experts at Monash University highlights the risks of global warming for individuals with cardiovascular issues. (earth.com)
  • This is a landmark study because it is the first study in about 20 years showing that a new approach to the treatment of T2D is associated with a significant decrease in cardiovascular mortality. (medscape.com)
  • Previous studies have found a decrease in the link between extreme heat and cardiovascular deaths, suggesting that people may have adapted to the warming climate. (earth.com)